Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.95 USD | +1.24% | -0.19% | -27.51% |
May. 23 | Transcript : Progyny, Inc. - Shareholder/Analyst Call | |
May. 22 | Progyny Gets Board Approval for $100 Million Share Repurchase Program; Stock Rises After Hours | MT |
Financials (USD)
Sales 2024 * | 1.24B | Sales 2025 * | 1.46B | Capitalization | 2.57B |
---|---|---|---|---|---|
Net income 2024 * | 72M | Net income 2025 * | 98M | EV / Sales 2024 * | 1.86 x |
Net cash position 2024 * | 269M | Net cash position 2025 * | 480M | EV / Sales 2025 * | 1.43 x |
P/E ratio 2024 * |
37.4
x | P/E ratio 2025 * |
27.7
x | Employees | 565 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.49% |
Latest transcript on Progyny, Inc.
1 day | +1.24% | ||
1 week | -0.19% | ||
1 month | -16.54% | ||
3 months | -25.18% | ||
6 months | -22.09% | ||
Current year | -27.51% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Anevski
CEO | Chief Executive Officer | 56 | 16-12-31 |
Michael Sturmer
PSD | President | 47 | 21-02-28 |
Mark Livingston
DFI | Director of Finance/CFO | 58 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 10-04-30 |
Kevin Gordon
BRD | Director/Board Member | 61 | 19-09-30 |
Norman Payson
BRD | Director/Board Member | 49 | 16-12-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 430 M€ | -.--% | ||
0.10% | 43 M€ | +4.17% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 26.95 | +1.24% | 987,473 |
24-05-30 | 26.62 | +1.22% | 834,098 |
24-05-29 | 26.3 | -1.39% | 2,006,723 |
24-05-28 | 26.67 | -1.22% | 1,226,409 |
24-05-24 | 27 | -0.55% | 1,059,805 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.51% | 2.57B | |
+14.19% | 125B | |
+15.08% | 97.9B | |
-21.78% | 43.15B | |
-3.53% | 38.2B | |
-12.93% | 18.43B | |
-8.59% | 1.51B | |
+15.53% | 546M |
- Stock Market
- Equities
- PGNY Stock